# Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.

> **NCT04046029** · PHASE4 · UNKNOWN · sponsor: **The First Affiliated Hospital of Dalian Medical University** · enrollment: 240 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Percutaneous Coronary Intervention
- Aging
- Anticoagulants and Bleeding Disorders

## Interventions

- **DRUG:** Bivalirudin
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT04046029
- **Lead sponsor:** The First Affiliated Hospital of Dalian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-08
- **Primary completion:** 2020-07-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2019-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04046029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04046029, "Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04046029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*